本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Apogee Therapeutics

72.35
+1.432.01%
成交量:25.35萬
成交額:1,827.09萬
市值:50.27億
市盈率:-17.16
高:73.15
開:70.26
低:69.11
收:70.92
52周最高:84.56
52周最低:26.20
股本:6,948.52萬
流通股本:5,245.49萬
量比:0.40
換手率:0.48%
股息:- -
股息率:- -
每股收益(TTM):-4.2155
每股收益(LYR):-4.2155
淨資產收益率:-31.57%
總資產收益率:-21.11%
市淨率:5.56
市盈率(LYR):-17.16

資料載入中...

2026/03/02

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/02

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/02

重要事件披露

Form 8-K - Current report
2026/02/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/01/06

重要事件披露

Form 8-K - Current report
2026/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/12/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/11/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/10

重要事件披露

Form 8-K - Current report
2025/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/10/10

重要事件披露

Form 8-K - Current report
2025/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]